Inventor · disambiguated record
Zhu Alexander Cao
Also filed as: CAO ZHU · CAO ZHU ALEXANDER
5 granted patents·13 pending applications·7 citations·filing 2013–2022
69Inventor score
Top patents by PatentIndex Score
18 records- 0189US10485788B2Pharmaceutical combinationsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 26, 2019·5 cites·23 claims
- 0271US11376239B2Pharmaceutical combinationsARRAY BIOPHARMA INC·Filed 2019·Granted Jul 5, 2022·0 cites·16 claims
- 0370US2023044943A1Pharmaceutical CombinationsARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 0461US2015290204A1Combination therapyNOVARTIS AG·Filed 2013·Application pending·0 cites
- 0559US8961970B2Combination therapyHUANG XIZHONG·Filed 2013·Granted Feb 24, 2015·1 cites·10 claims
- 0659US2021000951A1Combination therapiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0757US8980259B2Combination therapyHUANG XIZHONG·Filed 2013·Granted Mar 17, 2015·1 cites·16 claims
- 0857US2016375024A1Combination therapy comprising an inhibitor of jak, cdk, and pimCAO ZHU ALEXANDER·Filed 2014·Application pending·0 cites
- 0954US2020030442A1Combination therapiesCAO ZHU ALEXANDER·Filed 2019·Application pending·0 cites
- 1052US2019290627A1Pim kinase inhibitor combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1152US2018071296A1Combination therapy comprising an inhibitor of jak, cdk, and pimNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1249US2016175293A1Pim kinase inhibitor combinationsCAO ZHU ALEXANDER·Filed 2014·Application pending·0 cites
- 1348US2017157134A1Combination therapyNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1448US2017368044A1Pim kinase inhibitor combinationsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1546US2017209574A1Combination therapiesCAO ZHU ALEXANDER·Filed 2015·Application pending·0 cites
- 1644US2016287605A1Combination therapySHENG QING·Filed 2016·Application pending·0 cites
- 1736US2017340733A1Combination therapiesCAO ZHU ALEXANDER·Filed 2015·Application pending·0 cites
- 1830US11001628B2Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancerNOVARTIS AG·Filed 2016·Granted May 11, 2021·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →